Company / Debt per Share
Organon & Co. Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$33.53
FY2025
5-year range
$33.53 / $36.02
FY2021-FY2025
Trend
-3.5%
vs FY2024
Sector context
#8 of 82
Health Care
What the data says
Among 82 Health Care companies, Organon & Co. is in the bottom 10% for debt per share. Debt per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2020 to $36.02 in FY2021.
Based on SEC 10-K filings.
33.53 in FY2025 with a 3-year CAGR of -1.6%. Top quartile in the Health Care sector.
Improved from $34.44 to $33.53 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -1.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 82This company $33.53 Sector average $126.59
▼
-73.5% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 3.5% year-over-year.
- Ranks #8 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2021.
- Lowest debt per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $33.53 | -3.5% |
| FY2024 | $34.74 | +0.9% |
| FY2023 | $34.44 | -2.0% |
| FY2022 | $35.15 | -2.4% |
| FY2021 | $36.02 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026